Novartis receives FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis Pharmaceutical Investing
Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 Pharmaceutical Investing
Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma Biotech Investing
Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results Biotech Investing
Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH Biotech Investing
Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome Pharmaceutical Investing
Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M Pharmaceutical Investing
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva Biotech Investing
GW Pharmaceuticals Reports Fiscal First Quarter 2018 Financial Results and Operational Progress Life Science Investing
